FULCRUM THERAPEUTICS
3,6150
07-октября-24 11:19:17
15 мин. задержка
Акции
-0,2050
-5,37%
Сегодняшний диапазон
3,6000 - 3,7800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
15 май 2023 06:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
15 май 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
08 май 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 май 2023 17:06:50 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 апр 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CFO Resignation
05 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 мар 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
09 мар 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
06 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
24 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 фев 2023 16:27:22 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
08 фев 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
17 янв 2023 22:15:16 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
17 янв 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 янв 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
04 янв 2023 06:02:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 янв 2023 06:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 дек 2022 16:20:59 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
01 дек 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 ноя 2022 17:33:20 Источник Nasdaq GlobeNewswire